Citation Impact
Citing Papers
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Computational Thermostabilization of an Enzyme
2005 StandoutScienceNobel
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
1996
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
2004
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
2004
Fluorinated nucleosides: Synthesis and biological implication
2008
Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine
2014
Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
2018
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
2014
Hepatitis C Virus Infection
2001 Standout
Vaccines to prevent genital herpes
2020
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Treatment triumphs
2014 StandoutNatureNobel
Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability
2008
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
2011
An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs
2017
Clevudine: a potent inhibitor of hepatitis B virusin vitroandin vivo
2006
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
1993 Standout
Efficacy Results of a Trial of a Herpes Simplex Vaccine
2012
Enzyme and Pathway Engineering for Suicide Gene Therapy
2006
Biocompatible Carbon Nanotubes Generated by Functionalization with Glycodendrimers
2008 StandoutNobel
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
2007 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis
2012
Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women
2013
Hepatitis B virus infection
2009 Standout
Newer Methods for Diagnosis of Cytomegalovirus Infection
1990
Severe Sepsis and Septic Shock
2013 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
SYNTHESIS OF 1-(2-DEOXY-β-D - RIBOFURANOSYL)-2,4-DIFLUORO-5-SUBSTITUTED-BENZENE THYMIDINE MIMICS,*SOME RELATED α-ANOMERS, AND THEIR EVALUATION AS ANTIVIRAL AND ANTICANCER AGENTS
2001
Multiple sclerosis
2008 Standout
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti‐viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
2008
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Dendrimers in biomedical applications—reflections on the field
2005 Standout
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
1994
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Clevudine myopathy in patients with chronic hepatitis B
2009
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
1991
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
2014
IgG Subclass Distribution of Hepatitis B Surface Antigen Antibodies Induced in Children with Chronic Hepatitis B Infection after Interferon‐α Therapy
2000
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Time Trends in First-Episode Genital Herpes Simplex Virus Infections in an Urban Sexually Transmitted Disease Clinic
2019
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
2008
Genital herpes
2007
C5-Modified nucleosides exhibiting anticancer activity
2009
Multiple Sclerosis
2000 Standout
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
2005 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
2007
l-Nucleoside enantiomers as antivirals drugs: A mini-review
2006
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies
2007
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Interferon-β downregulates interferon-γ-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells
1995
Formulating a Sulfonated Antiviral Dendrimer in a Vaginal Microbicidal Gel Having Dual Mechanisms of Action
2008
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Infection in Organ-Transplant Recipients
1998 Standout
The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics
2004
25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end
2013
Impact of Cytomegalovirus Infection on Organ Transplant Recipients
1990
The biological cost of antimicrobial resistance
1997
Chemical pathology of acute demyelinating lesions and its correlation with disability
1995
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
2015
Multiple sclerosis
2002 Standout
Dendrimers in drug research
2003
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Fluorine in medicinal chemistry
2007 Standout
Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone
2011
A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine
2008
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
Supramolecular Coordination: Self-Assembly of Finite Two- and Three-Dimensional Ensembles
2011 Standout
Preclinical Safety and Efficacy Assessments of Dendrimer-Based (SPL7013) Microbicide Gel Formulations in a Nonhuman Primate Model
2006
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
2010
Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach To Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes
2014
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Development of resistance during antibiotic therapy
1987
Placebo‐Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV‐1 Infection
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Effect of Dextran as a Run Buffer Additive in Drug−Protein Binding Studies Using Capillary Electrophoresis Frontal Analysis
2002
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves as a Potent Th1-Tilting Adjuvant for Recombinant gD2 Protein Vaccination against Genital Herpes
2006
A comparison of randomised controlled trials in health and education
2005
Nanoparticles in Photodynamic Therapy
2015 Standout
Empirical Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from Four EORTC Trials
1988
Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection
2008
Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model
2015
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
2014 StandoutNobel
Education, HIV, and Early Fertility: Experimental Evidence from Kenya
2015 StandoutNobel
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 StandoutNobel
Dendrimers as Drugs: Discovery and Preclinical and Clinical Development of Dendrimer-Based Microbicides for HIV and STI Prevention
2005
A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia
1986
The Crisis in Antibiotic Resistance
1992 StandoutScience
Acyclic C-nucleosides: synthesis of chiral 1,1-diheteroaryl-alditols and X-ray crystal structure of 2,3,5-tri-O-benzyl-1,1-di-(2′-pyrryl)-1-deoxy-d-arabinitol
1997
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
2020
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study
2020
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Antibacterial Activities of Poly(amidoamine) Dendrimers Terminated with Amino and Poly(ethylene glycol) Groups
2007
Aromatic Trifluoromethylation with Metal Complexes
2011 Standout
Safe prevention of the primary cesarean delivery
2014 Standout
Electrochemical Glucose Biosensors
2007 Standout
Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/ nucleotide inhibitors
2009
Modeling the Multivalent Recognition between Dendritic Molecules and DNA: Understanding How Ligand “Sacrifice” and Screening Can Enhance Binding
2009
Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections
2012
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Synthesis and Biological Evaluation of 6-(Alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one Base and Nucleoside Derivatives
2005
Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon
1986
Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity
2020
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
2019 StandoutNobel
Clinical Translation of Nanomedicine
2015
Works of Stephen L. Sacks being referenced
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
2002
Nucleic acid related compounds. 65. New syntheses of 1-(.beta.-D-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVAraU) from vinylsilane precursors. Radioiodine uptake as a marker for thymidine kinase herpes viral infections
1991
Docosanol: a topical antiviral for herpes labialis
2004
Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial
2007
Famciclovir Suppression of Asymptomatic and Symptomatic Recurrent Anogenital Herpes Simplex Virus Shedding in Women: A Randomized, Double‐Blind, Double‐Dummy, Placebo‐Controlled, Parallel‐Group, Single‐Center Trial
2004
Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication
2002
Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes
2003
Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses
2005
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
2004
A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery
2003
Progressive Esophagitis from Acyclovir-Resistant Herpes Simplex
1989
Cytomegalovirus hepatitis: Evidence for direct hepatic viral infection using monoclonal antibodies
1984
Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections
1983
Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation
1990
New Antiherpesvirus Agents
1996
Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group
1996
Quantitative description of analyte migration behavior based on the dynamic complexation model in capillary electrophoresis
1997
Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside
1981